EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
TSX:EXE - Toronto Stock Exchange - CA30224T8639 - Common Stock - Currency: CAD
We assign a fundamental rating of 6 out of 10 to EXE. EXE was compared to 15 industry peers in the Health Care Providers & Services industry. While EXE has a great profitability rating, there are quite some concerns on its financial health. EXE has a correct valuation and a medium growth rate. Finally EXE also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
In the past year EXE had a positive cash flow from operations.
Each year in the past 5 years EXE has been profitable.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
EXE has a Return On Assets of 10.81%. This is amongst the best in the industry. EXE outperforms 86.67% of its industry peers.
With an excellent Return On Equity value of 61.61%, EXE belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
The Return On Invested Capital of EXE (20.15%) is better than 100.00% of its industry peers.
EXE had an Average Return On Invested Capital over the past 3 years of 11.40%. This is above the industry average of 8.13%.
The 3 year average ROIC (11.40%) for EXE is below the current ROIC(20.15%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROIC | 20.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
With a decent Profit Margin value of 5.23%, EXE is doing good in the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Profit Margin of EXE has grown nicely.
The Operating Margin of EXE (7.91%) is better than 73.33% of its industry peers.
In the last couple of years the Operating Margin of EXE has grown nicely.
EXE has a Gross Margin of 14.04%. This is amonst the worse of the industry: EXE underperforms 86.67% of its industry peers.
EXE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
EXE has more shares outstanding than it did 1 year ago.
EXE has less shares outstanding than it did 5 years ago.
EXE has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.89 indicates that EXE is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.89, EXE belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
EXE has a debt to FCF ratio of 128.12. This is a negative value and a sign of low solvency as EXE would need 128.12 years to pay back of all of its debts.
With a Debt to FCF ratio value of 128.12, EXE perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
EXE has a Debt/Equity ratio of 2.16. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.16, EXE is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Altman-Z | 2.89 |
ROIC/WACC2.92
WACC6.91%
2.3 Liquidity
EXE has a Current Ratio of 0.84. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Current ratio of 0.84. This is comparable to the rest of the industry: EXE outperforms 53.33% of its industry peers.
A Quick Ratio of 0.84 indicates that EXE may have some problems paying its short term obligations.
With a Quick ratio value of 0.84, EXE perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 115.90% over the past year.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
EXE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.38%.
EXE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.31% yearly.
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
3.2 Future
The Earnings Per Share is expected to grow by 8.74% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.74% on average over the next years.
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.74%
Revenue Next Year11.29%
Revenue Next 2Y9.56%
Revenue Next 3Y6.68%
Revenue Next 5Y4.74%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.78, which indicates a correct valuation of EXE.
Based on the Price/Earnings ratio, EXE is valued cheaper than 86.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.82, EXE is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.02, which indicates a correct valuation of EXE.
Based on the Price/Forward Earnings ratio, EXE is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of EXE to the average of the S&P500 Index (36.21), we can say EXE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.78 | ||
| Fwd PE | 14.02 |
4.2 Price Multiples
EXE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EXE is cheaper than 86.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXE is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 459.34 | ||
| EV/EBITDA | 8.04 |
4.3 Compensation for Growth
EXE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.65
EPS Next 2Y4.74%
EPS Next 3Y7.81%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 4.09%, which is a nice return.
EXE's Dividend Yield is rather good when compared to the industry average which is at 3.38. EXE pays more dividend than 86.67% of the companies in the same industry.
EXE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.09% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EXE pays out 51.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.91%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
TSX:EXE (8/1/2025, 7:00:00 PM)
12.27
-0.06 (-0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.58%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.03B
Analysts74
Price Target16.41 (33.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.09% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP51.91%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)18.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.15%
Revenue NY rev (3m)3.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.78 | ||
| Fwd PE | 14.02 | ||
| P/S | 0.7 | ||
| P/FCF | 459.34 | ||
| P/OCF | 20.46 | ||
| P/B | 8.21 | ||
| P/tB | 171.35 | ||
| EV/EBITDA | 8.04 |
EPS(TTM)0.83
EY6.76%
EPS(NY)0.88
Fwd EY7.13%
FCF(TTM)0.03
FCFY0.22%
OCF(TTM)0.6
OCFY4.89%
SpS17.58
BVpS1.49
TBVpS0.07
PEG (NY)N/A
PEG (5Y)0.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROCE | 26.66% | ||
| ROIC | 20.15% | ||
| ROICexc | 26.88% | ||
| ROICexgc | 42.25% | ||
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% | ||
| FCFM | 0.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexcg growth 3Y72.34%
ROICexcg growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score7
Asset Turnover2.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 143.57% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 9.47 | ||
| Cash Conversion | 33.51% | ||
| Profit Quality | 2.9% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 2.89 |
F-Score7
WACC6.91%
ROIC/WACC2.92
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.74%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
Revenue Next Year11.29%
Revenue Next 2Y9.56%
Revenue Next 3Y6.68%
Revenue Next 5Y4.74%
EBIT growth 1Y90.12%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-5.03%
EBIT Next 3Y4.16%
EBIT Next 5Y2.88%
FCF growth 1Y102.3%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y173.94%
OCF growth 3Y31.32%
OCF growth 5Y26.02%